Trescal, a portfolio company of OMERS Private Equity, has acquired RS Calibration, a Pleasanton, California based A2LA accredited calibration, qualification and validation laboratory dedicated to the life science industry.
Ralph Sabiel, founder and CEO of RS, will remain in his current position to pursue the development of the company within Trescal Group.
This acquisition is the first add-on acquisition subsequent to OMERS Private Equity becoming controlling shareholder in April 2018.
OMERS Private Equity, in partnership with Trescal’s management team led by its CEO Olivier Delrieu, acquired Trescal from Ardian, valuing Trescal at approximately €670 million.
Paris based Trescal is a leading international specialist for calibration services with presence in 22 countries.
photo credit: RS Calibration
News Release
24/05/2018
TRESCAL ACQUIRES RS CALIBRATION IN CALIFORNIA (USA)
Trescal announces the acquisition of RS Calibration, an A2LA accredited calibration, qualification and validation laboratory dedicated to the life science industry
Founded in 1995 and based in Pleasanton (Northeast of San Francisco), RS Calibration employs 41 people and provides in house or on site calibration and validation services specifically for the Pharmaceutical, Medical Device, and Biotech production environments. The company has high calibration expertise in the FDA and cGMP environments and its sales reached $ 5,5 million in 2017.
The CEO and founder, Ralph Sabiel, will remain in his current position to pursue the development of the company within Trescal Group.
Guillaume Caroit, Trescal Deputy CEO, said: “This acquisition is very important for the development of Trescal in the United States. It will strengthen our coverage in California and reinforces our ability to serve the life science industry. ”
This acquisition is the first to be completed subsequent to OMERS, the defined benefit pension plan for municipal employees in the Province of Ontario, Canada, becoming Trescal’s main shareholder.